Informatie:
Fout:
ID
22954
Beschrijving
Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM; ODM derived from: https://clinicaltrials.gov/show/NCT00515801
Link
https://clinicaltrials.gov/show/NCT00515801
Trefwoorden
Versies (1)
- 18-06-17 18-06-17 -
Geüploaded op
18 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Mellitus, Type 1 NCT00515801
Eligibility Diabetes Mellitus, Type 1 NCT00515801
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 1 NCT00515801
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients aged 18 to 50 years
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
patients diagnosed with c-peptide negative diabetes type 1 (c-peptide <200 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
boolean
C0202100 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
ID.3
Item
patients diagnosed with c-peptide positive diabetes type 1 (c-peptide > 500 pmol/l 6 min after 1 mg glucagon i.v. at plasma glucose concentrations between 5 and 11 mmol/l)
boolean
C0202100 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
C0011854 (UMLS CUI [1,2])
C2584434 (UMLS CUI [1,3])
ID.4
Item
stable metabolic control; hba1c levels <8.0 % and without episodes of antecedent severe hypoglycemias in the past four weeks
boolean
C0019018 (UMLS CUI [1,1])
C0150254 (UMLS CUI [1,2])
C0150254 (UMLS CUI [1,2])
ID.5
Item
patients treated with medications potentially interfering with glucose metabolism, such as systemic steroids, immunosuppressive drugs (cyclosporine, tacrolimus, sirolimus), highly active antiretroviral therapy
boolean
C0038317 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
C0021081 (UMLS CUI [1,2])
ID.6
Item
history coronary artery disease
boolean
C1956346 (UMLS CUI [1])
ID.7
Item
history of epilepsy or seizures
boolean
C0014544 (UMLS CUI [1,1])
C0036572 (UMLS CUI [1,2])
C0036572 (UMLS CUI [1,2])
ID.8
Item
current smokers
boolean
C0337664 (UMLS CUI [1])
ID.9
Item
any significant or unstable hepatic, cardiac, pulmonary, renal, neurological, musculoskeletal, hematological or endocrine disease.
boolean
C0012634 (UMLS CUI [1])
ID.10
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.11
Item
woman of childbearing potential not using a reliable method of birth control such as oral contraceptives or iud.
boolean
C0009862 (UMLS CUI [1])
ID.12
Item
subjects refusing or unable to give written informed consent
boolean
C0021430 (UMLS CUI [1])